Paul MacLean
Concepts (667)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 59 | 2026 | 3057 | 5.200 |
Why?
| | Weight Gain | 26 | 2023 | 556 | 4.420 |
Why?
| | Energy Metabolism | 33 | 2025 | 935 | 4.330 |
Why?
| | Weight Loss | 28 | 2026 | 832 | 4.190 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 243 | 2.360 |
Why?
| | Rats, Wistar | 19 | 2024 | 451 | 2.190 |
Why?
| | Energy Intake | 18 | 2025 | 499 | 2.110 |
Why?
| | Dietary Fats | 15 | 2026 | 313 | 1.970 |
Why?
| | Caloric Restriction | 9 | 2025 | 127 | 1.720 |
Why?
| | Ovariectomy | 11 | 2025 | 162 | 1.690 |
Why?
| | Body Weight | 16 | 2024 | 976 | 1.470 |
Why?
| | Lactation | 8 | 2020 | 192 | 1.430 |
Why?
| | Adipose Tissue | 15 | 2022 | 651 | 1.380 |
Why?
| | Appetite | 3 | 2025 | 69 | 1.330 |
Why?
| | Diet, High-Fat | 15 | 2023 | 261 | 1.300 |
Why?
| | Milk, Human | 6 | 2022 | 172 | 1.240 |
Why?
| | Body Composition | 12 | 2024 | 704 | 1.190 |
Why?
| | Ovary | 5 | 2024 | 228 | 1.140 |
Why?
| | Rats | 34 | 2024 | 5592 | 1.120 |
Why?
| | Adipocytes | 7 | 2025 | 223 | 1.100 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1792 | 1.060 |
Why?
| | Overweight | 7 | 2026 | 606 | 1.060 |
Why?
| | Animals | 87 | 2026 | 38030 | 1.040 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 1.010 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 79 | 1.010 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 142 | 0.940 |
Why?
| | Lipid Metabolism | 9 | 2017 | 525 | 0.930 |
Why?
| | Motor Activity | 3 | 2019 | 720 | 0.930 |
Why?
| | Appetite Regulation | 2 | 2017 | 31 | 0.850 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 569 | 0.800 |
Why?
| | Biomedical Research | 3 | 2023 | 709 | 0.780 |
Why?
| | Liver | 11 | 2024 | 1884 | 0.760 |
Why?
| | Cholesterol | 5 | 2019 | 399 | 0.760 |
Why?
| | Fasting | 7 | 2025 | 276 | 0.750 |
Why?
| | Milk | 6 | 2019 | 119 | 0.750 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 249 | 0.750 |
Why?
| | Leptin | 8 | 2025 | 244 | 0.740 |
Why?
| | Vasopressins | 3 | 2021 | 60 | 0.740 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.740 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 319 | 0.740 |
Why?
| | Awards and Prizes | 1 | 2023 | 70 | 0.730 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 17 | 0.730 |
Why?
| | Eating | 5 | 2022 | 389 | 0.730 |
Why?
| | Estrogens | 3 | 2018 | 380 | 0.730 |
Why?
| | Lipogenesis | 3 | 2019 | 62 | 0.720 |
Why?
| | Breast Feeding | 5 | 2022 | 448 | 0.720 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 128 | 0.700 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 70 | 0.700 |
Why?
| | Glycoproteins | 5 | 2005 | 355 | 0.680 |
Why?
| | Receptor, Insulin | 3 | 2015 | 94 | 0.670 |
Why?
| | Insulin | 19 | 2022 | 2501 | 0.650 |
Why?
| | Estradiol | 1 | 2024 | 533 | 0.640 |
Why?
| | Exercise | 11 | 2025 | 2193 | 0.620 |
Why?
| | Female | 69 | 2026 | 77976 | 0.620 |
Why?
| | Weight Reduction Programs | 4 | 2026 | 135 | 0.620 |
Why?
| | Oxygen Consumption | 5 | 2019 | 724 | 0.620 |
Why?
| | Breast Neoplasms | 7 | 2026 | 2447 | 0.610 |
Why?
| | Thermogenesis | 2 | 2019 | 45 | 0.610 |
Why?
| | Physical Exertion | 3 | 2011 | 207 | 0.610 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 214 | 0.610 |
Why?
| | Carrier Proteins | 6 | 2005 | 736 | 0.590 |
Why?
| | Cold Temperature | 2 | 2019 | 207 | 0.580 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 674 | 0.560 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 121 | 0.550 |
Why?
| | Menopause | 2 | 2019 | 319 | 0.550 |
Why?
| | Sex Characteristics | 3 | 2021 | 789 | 0.550 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 58 | 0.540 |
Why?
| | Calorimetry, Indirect | 6 | 2025 | 83 | 0.520 |
Why?
| | Diet | 10 | 2023 | 1271 | 0.520 |
Why?
| | Adipogenesis | 1 | 2017 | 57 | 0.520 |
Why?
| | Cortical Bone | 1 | 2017 | 15 | 0.520 |
Why?
| | Insulin Resistance | 9 | 2025 | 1232 | 0.510 |
Why?
| | Mice | 35 | 2026 | 18329 | 0.510 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.510 |
Why?
| | Adiposity | 5 | 2016 | 541 | 0.500 |
Why?
| | Diet, Reducing | 4 | 2021 | 91 | 0.500 |
Why?
| | Ibuprofen | 1 | 2017 | 84 | 0.500 |
Why?
| | Metformin | 2 | 2018 | 315 | 0.500 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.480 |
Why?
| | Placenta | 1 | 2023 | 780 | 0.480 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.480 |
Why?
| | Osteogenesis | 2 | 2017 | 206 | 0.470 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2603 | 0.470 |
Why?
| | Bone Density | 1 | 2019 | 482 | 0.460 |
Why?
| | Body Mass Index | 12 | 2026 | 2420 | 0.450 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.450 |
Why?
| | Fructose | 5 | 2021 | 129 | 0.450 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 457 | 0.450 |
Why?
| | Male | 62 | 2026 | 72035 | 0.440 |
Why?
| | Therapies, Investigational | 1 | 2014 | 18 | 0.430 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 100 | 0.430 |
Why?
| | Humans | 75 | 2026 | 144261 | 0.430 |
Why?
| | Mothers | 4 | 2018 | 774 | 0.430 |
Why?
| | Feces | 7 | 2025 | 513 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.410 |
Why?
| | Transcription Factors | 13 | 2019 | 1739 | 0.410 |
Why?
| | Fatty Acids | 8 | 2022 | 450 | 0.400 |
Why?
| | Basal Metabolism | 3 | 2021 | 62 | 0.390 |
Why?
| | Fructokinases | 5 | 2021 | 41 | 0.390 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 56 | 0.380 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4556 | 0.380 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.370 |
Why?
| | Fatty Liver | 5 | 2018 | 251 | 0.370 |
Why?
| | Pregnancy | 10 | 2023 | 7180 | 0.360 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 79 | 0.360 |
Why?
| | Blood Glucose | 10 | 2019 | 2312 | 0.360 |
Why?
| | Feeding Behavior | 5 | 2025 | 681 | 0.350 |
Why?
| | Recurrence | 4 | 2019 | 1134 | 0.340 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1092 | 0.340 |
Why?
| | Sheep | 4 | 2023 | 880 | 0.340 |
Why?
| | Estrous Cycle | 1 | 2010 | 23 | 0.320 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 356 | 0.320 |
Why?
| | Lipoproteins | 3 | 2000 | 163 | 0.320 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.320 |
Why?
| | Homeostasis | 7 | 2015 | 640 | 0.320 |
Why?
| | RNA, Messenger | 10 | 2019 | 2829 | 0.310 |
Why?
| | Gastrointestinal Microbiome | 4 | 2026 | 771 | 0.310 |
Why?
| | Vitamin D | 1 | 2013 | 399 | 0.300 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 161 | 0.300 |
Why?
| | Glucose | 10 | 2023 | 1046 | 0.300 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 24 | 0.300 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 139 | 0.290 |
Why?
| | Huntington Disease | 2 | 2021 | 61 | 0.280 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 150 | 0.280 |
Why?
| | Cattle | 6 | 2025 | 999 | 0.280 |
Why?
| | Mice, Inbred C57BL | 17 | 2026 | 5988 | 0.280 |
Why?
| | Time Factors | 11 | 2019 | 7155 | 0.280 |
Why?
| | Behavior Therapy | 2 | 2021 | 281 | 0.280 |
Why?
| | Adult | 34 | 2026 | 40262 | 0.280 |
Why?
| | Mice, Knockout | 13 | 2026 | 3119 | 0.270 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 35 | 0.260 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1255 | 0.260 |
Why?
| | Triglycerides | 8 | 2019 | 512 | 0.250 |
Why?
| | Adiponectin | 5 | 2025 | 243 | 0.250 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 67 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 573 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1640 | 0.240 |
Why?
| | Intestinal Absorption | 2 | 2026 | 103 | 0.240 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2192 | 0.240 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 290 | 0.240 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 16 | 0.240 |
Why?
| | Birds | 2 | 2025 | 92 | 0.240 |
Why?
| | Dehydration | 2 | 2016 | 56 | 0.240 |
Why?
| | Campylobacter jejuni | 1 | 2025 | 16 | 0.240 |
Why?
| | Campylobacter Infections | 1 | 2025 | 18 | 0.230 |
Why?
| | Lymphoma | 1 | 2007 | 232 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2025 | 26 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2516 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 181 | 0.230 |
Why?
| | Epithelium | 2 | 2019 | 314 | 0.230 |
Why?
| | Transcriptome | 4 | 2024 | 1044 | 0.230 |
Why?
| | Adenocarcinoma | 1 | 2012 | 927 | 0.230 |
Why?
| | Signal Transduction | 6 | 2022 | 5221 | 0.220 |
Why?
| | Fetal Development | 3 | 2023 | 299 | 0.220 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 352 | 0.220 |
Why?
| | Muscle Proteins | 4 | 2012 | 244 | 0.220 |
Why?
| | Leukemia | 1 | 2007 | 245 | 0.220 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 420 | 0.210 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1497 | 0.210 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.210 |
Why?
| | Physical Fitness | 2 | 2016 | 209 | 0.200 |
Why?
| | Multiple Myeloma | 1 | 2007 | 291 | 0.200 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2026 | 233 | 0.200 |
Why?
| | Escherichia coli O157 | 1 | 2023 | 35 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 269 | 0.200 |
Why?
| | Animals, Newborn | 3 | 2017 | 901 | 0.200 |
Why?
| | Middle Aged | 25 | 2026 | 35762 | 0.200 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 22 | 0.200 |
Why?
| | Resistance Training | 3 | 2017 | 180 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 84 | 0.190 |
Why?
| | Salmonella enterica | 1 | 2023 | 59 | 0.190 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.190 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 442 | 0.190 |
Why?
| | Transcriptional Activation | 2 | 2002 | 382 | 0.190 |
Why?
| | Animal Feed | 3 | 2019 | 53 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2017 | 2494 | 0.190 |
Why?
| | Ghrelin | 3 | 2025 | 38 | 0.190 |
Why?
| | Hospitalization | 1 | 2013 | 2424 | 0.190 |
Why?
| | Parturition | 1 | 2023 | 68 | 0.180 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1084 | 0.180 |
Why?
| | Tamoxifen | 3 | 2021 | 217 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 149 | 0.180 |
Why?
| | Exercise Tolerance | 3 | 2016 | 283 | 0.180 |
Why?
| | Postmenopause | 4 | 2022 | 391 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1455 | 0.170 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 59 | 0.170 |
Why?
| | Mycoplasma ovipneumoniae | 1 | 2021 | 2 | 0.170 |
Why?
| | Malus | 1 | 2021 | 12 | 0.170 |
Why?
| | Lactoglobulins | 2 | 2018 | 6 | 0.170 |
Why?
| | Recombinases | 1 | 2021 | 8 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 20 | 0.170 |
Why?
| | Cancer Survivors | 1 | 2026 | 326 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 218 | 0.170 |
Why?
| | Thinness | 3 | 2021 | 99 | 0.170 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.160 |
Why?
| | Liver X Receptors | 2 | 2019 | 30 | 0.160 |
Why?
| | Cinnamates | 1 | 2000 | 12 | 0.160 |
Why?
| | Child Development | 2 | 2018 | 484 | 0.160 |
Why?
| | Disease Progression | 4 | 2018 | 2840 | 0.160 |
Why?
| | DNA Methylation | 2 | 2017 | 681 | 0.160 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2021 | 55 | 0.160 |
Why?
| | Gene Expression Profiling | 3 | 2018 | 1782 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2001 | 113 | 0.160 |
Why?
| | Shiga-Toxigenic Escherichia coli | 1 | 2020 | 15 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.160 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 194 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 152 | 0.160 |
Why?
| | Random Allocation | 2 | 2019 | 363 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1495 | 0.150 |
Why?
| | Starch | 1 | 2019 | 22 | 0.150 |
Why?
| | Nutritive Value | 1 | 2019 | 38 | 0.150 |
Why?
| | Escherichia coli Infections | 1 | 2020 | 129 | 0.150 |
Why?
| | Soil | 1 | 2021 | 214 | 0.150 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 449 | 0.150 |
Why?
| | Weaning | 1 | 2019 | 46 | 0.150 |
Why?
| | Foodborne Diseases | 1 | 2020 | 61 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1165 | 0.150 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.150 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2019 | 40 | 0.150 |
Why?
| | Metabolic Diseases | 2 | 2018 | 113 | 0.150 |
Why?
| | Analysis of Variance | 4 | 2016 | 1304 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 121 | 0.140 |
Why?
| | Ileitis | 1 | 2019 | 33 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2021 | 242 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2525 | 0.140 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 59 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 198 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2182 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Milk Hypersensitivity | 1 | 2018 | 18 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 34 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 32 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 164 | 0.140 |
Why?
| | Dairying | 3 | 2025 | 12 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 54 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.140 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Rest | 1 | 2018 | 124 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.130 |
Why?
| | Postpartum Period | 2 | 2020 | 361 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 59 | 0.130 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 587 | 0.130 |
Why?
| | Malnutrition | 1 | 2019 | 86 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 92 | 0.130 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Urea | 1 | 2017 | 84 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 112 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 83 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 79 | 0.130 |
Why?
| | Gene Editing | 1 | 2018 | 93 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 732 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 300 | 0.130 |
Why?
| | Running | 1 | 2019 | 228 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 32 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 64 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 197 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2018 | 171 | 0.120 |
Why?
| | Neural Pathways | 2 | 2011 | 311 | 0.120 |
Why?
| | Glaucoma | 1 | 2020 | 250 | 0.120 |
Why?
| | PPAR gamma | 1 | 2017 | 176 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 103 | 0.120 |
Why?
| | Dogs | 1 | 2018 | 437 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 321 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 153 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 55 | 0.120 |
Why?
| | Paratuberculosis | 1 | 2015 | 2 | 0.120 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2015 | 3 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2000 | 275 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 179 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 153 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 17 | 0.120 |
Why?
| | Jejunum | 1 | 2015 | 35 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 680 | 0.120 |
Why?
| | Down-Regulation | 3 | 2008 | 627 | 0.120 |
Why?
| | Deer | 1 | 2015 | 34 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 905 | 0.110 |
Why?
| | Up-Regulation | 3 | 2015 | 851 | 0.110 |
Why?
| | Fibroblasts | 2 | 2017 | 1032 | 0.110 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.110 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.110 |
Why?
| | Microbiota | 1 | 2023 | 781 | 0.110 |
Why?
| | Crohn Disease | 1 | 2019 | 260 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 624 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 353 | 0.110 |
Why?
| | Allergens | 1 | 2018 | 384 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 844 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Genetic Engineering | 1 | 2015 | 93 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1047 | 0.110 |
Why?
| | Trophoblasts | 1 | 2017 | 216 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 74 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 477 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 523 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 87 | 0.100 |
Why?
| | Arecaceae | 1 | 2014 | 3 | 0.100 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 276 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 38 | 0.100 |
Why?
| | Fetus | 1 | 2019 | 803 | 0.100 |
Why?
| | Genes, Plant | 1 | 2014 | 46 | 0.100 |
Why?
| | Infant | 5 | 2023 | 10022 | 0.100 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 522 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1715 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | United States | 3 | 2023 | 15876 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 236 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 983 | 0.100 |
Why?
| | Animals, Wild | 2 | 2025 | 61 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 59 | 0.100 |
Why?
| | Lipoproteins, HDL | 2 | 2026 | 89 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 120 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2009 | 513 | 0.100 |
Why?
| | Genome | 1 | 2015 | 306 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 122 | 0.090 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 8 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 307 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 210 | 0.090 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 676 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 134 | 0.090 |
Why?
| | Alleles | 1 | 2015 | 878 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 824 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 195 | 0.090 |
Why?
| | Histones | 1 | 2017 | 668 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1125 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1129 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 36 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 173 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 309 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2359 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2134 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 185 | 0.080 |
Why?
| | Biomarkers | 6 | 2019 | 4254 | 0.080 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 67 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 383 | 0.080 |
Why?
| | Glycolysis | 1 | 2012 | 339 | 0.080 |
Why?
| | Colon | 1 | 2013 | 304 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 585 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6424 | 0.080 |
Why?
| | Phylogeny | 3 | 2021 | 1015 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4562 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 20 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 42 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 982 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 379 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 40 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 313 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 264 | 0.080 |
Why?
| | Intestine, Small | 2 | 2026 | 166 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 261 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1254 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 574 | 0.080 |
Why?
| | Fats | 1 | 2009 | 17 | 0.070 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 194 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 199 | 0.070 |
Why?
| | Adolescent | 6 | 2025 | 22281 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 782 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 206 | 0.070 |
Why?
| | Young Adult | 6 | 2025 | 13990 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 160 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 863 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 365 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 346 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 190 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1379 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 437 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 600 | 0.070 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 558 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1732 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 27 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 174 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 88 | 0.060 |
Why?
| | Risk Factors | 3 | 2018 | 10699 | 0.060 |
Why?
| | Animals, Genetically Modified | 2 | 2018 | 250 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 187 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2016 | 11643 | 0.060 |
Why?
| | Patient Selection | 2 | 2009 | 719 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 107 | 0.060 |
Why?
| | Nuclear Transfer Techniques | 2 | 2017 | 5 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 316 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2879 | 0.060 |
Why?
| | Chylomicrons | 1 | 2026 | 19 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 83 | 0.060 |
Why?
| | Proof of Concept Study | 1 | 2026 | 85 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 634 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 186 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 72 | 0.060 |
Why?
| | Multilocus Sequence Typing | 1 | 2025 | 17 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 780 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 60 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 797 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 83 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 24 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2048 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 38 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 6 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 46 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3592 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1705 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 17009 | 0.050 |
Why?
| | Disease Resistance | 2 | 2015 | 29 | 0.050 |
Why?
| | Models, Biological | 2 | 2018 | 1820 | 0.050 |
Why?
| | Population Dynamics | 1 | 2025 | 158 | 0.050 |
Why?
| | Proteins | 2 | 2013 | 1021 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2926 | 0.050 |
Why?
| | Proteomics | 2 | 2022 | 1191 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 209 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 148 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1510 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1627 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 45 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 555 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 312 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 51 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1867 | 0.050 |
Why?
| | Manure | 1 | 2023 | 10 | 0.050 |
Why?
| | Colony Count, Microbial | 1 | 2023 | 122 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 634 | 0.050 |
Why?
| | Food Microbiology | 1 | 2023 | 73 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 381 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 266 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 27 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 315 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 40 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 275 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 21 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 302 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 111 | 0.050 |
Why?
| | Sex Factors | 2 | 2019 | 2096 | 0.050 |
Why?
| | Aged | 5 | 2018 | 25850 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 84 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 57 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2111 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2026 | 1461 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 78 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 61 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 40 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 83 | 0.040 |
Why?
| | Dinoprostone | 1 | 2022 | 178 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 139 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1087 | 0.040 |
Why?
| | Clostridium | 1 | 2021 | 19 | 0.040 |
Why?
| | Bacillus | 1 | 2021 | 17 | 0.040 |
Why?
| | Mice, Obese | 1 | 2021 | 66 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 144 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 220 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 271 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1134 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 75 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 138 | 0.040 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 39 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 211 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 319 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 74 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 42 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 358 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 85 | 0.040 |
Why?
| | Farms | 1 | 2020 | 8 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1833 | 0.040 |
Why?
| | Molecular Typing | 1 | 2020 | 21 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 383 | 0.040 |
Why?
| | Metabolomics | 1 | 2026 | 726 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 70 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 260 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 131 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 744 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 341 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 105 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 107 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2143 | 0.040 |
Why?
| | Plasmids | 1 | 2021 | 379 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 275 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 114 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 8 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2026 | 878 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 42 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 252 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 54 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8243 | 0.040 |
Why?
| | Ileostomy | 1 | 2019 | 25 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 50 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 115 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 214 | 0.040 |
Why?
| | Child | 2 | 2022 | 22537 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 36 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 136 | 0.030 |
Why?
| | Prospective Studies | 2 | 2023 | 7970 | 0.030 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 118 | 0.030 |
Why?
| | Colectomy | 1 | 2019 | 107 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 329 | 0.030 |
Why?
| | Japan | 1 | 2018 | 143 | 0.030 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5813 | 0.030 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1983 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 938 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 38 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 462 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 124 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 44 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2018 | 193 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 28 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2061 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 428 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 143 | 0.030 |
Why?
| | Breast | 1 | 2018 | 157 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 674 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 47 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 28 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 208 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 356 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 166 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 629 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 227 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 101 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 299 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2870 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 612 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2930 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 242 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 255 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 281 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 155 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1172 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 197 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 360 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 92 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 160 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 757 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 154 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 224 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 120 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 625 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 205 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 850 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 188 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2015 | 19 | 0.030 |
Why?
| | Biological Products | 1 | 2019 | 251 | 0.030 |
Why?
| | Endonucleases | 1 | 2015 | 34 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2015 | 53 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 454 | 0.030 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 35 | 0.030 |
Why?
| | Gestational Age | 1 | 2019 | 975 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 44 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1339 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 366 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4146 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2025 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1182 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 850 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 86 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1075 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 321 | 0.030 |
Why?
| | RNA, Plant | 1 | 2014 | 10 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2014 | 43 | 0.030 |
Why?
| | Genetic Loci | 1 | 2015 | 261 | 0.030 |
Why?
| | Gene Ontology | 1 | 2014 | 53 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 744 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 250 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 105 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 405 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 700 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 107 | 0.020 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 29 | 0.020 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.020 |
Why?
| | Plant Proteins | 1 | 2014 | 112 | 0.020 |
Why?
| | Betaine | 1 | 2013 | 65 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3403 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 157 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 333 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2019 | 592 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 502 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 158 | 0.020 |
Why?
| | Plant Leaves | 1 | 2014 | 137 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 684 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 143 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 147 | 0.020 |
Why?
| | Base Sequence | 1 | 2015 | 2187 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1759 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2815 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 758 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2917 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2929 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 824 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 318 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1487 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 44 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 508 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1906 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5389 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 90 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 15 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3539 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 477 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3637 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3157 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 514 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 405 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 700 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 621 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 228 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 29 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3857 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 63 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 31 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 30 | 0.010 |
Why?
| | PPAR alpha | 1 | 2006 | 54 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 33 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 242 | 0.010 |
Why?
| | Introns | 1 | 2005 | 254 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 216 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 4085 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 65 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 9 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 48 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 53 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 135 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 129 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 221 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2877 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 765 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1964 | 0.010 |
Why?
| | RNA | 1 | 2003 | 939 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 847 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 327 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 330 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 92 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3313 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1187 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 512 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|